我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
433
70 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1917
进行中（未招募）
15
3.5%
已完成
229
52.9%
Enrolling By Invitation
8
1.9%
尚未招募
47
10.8%
招募中
62
14.3%
终止
5
1.1%
Unknown
67
15.5%
暂无批准数据
- Anthrax, caused by Bacillus anthracis, remains a dangerous zoonotic disease with spores capable of surviving in the environment for decades, posing ongoing risks in endemic regions including Thailand. - Inhalational anthrax carries a mortality rate as high as 95% if a large number of spores are inhaled, making it the most alarming form of infection. - Effective antibiotic treatments exist, including penicillin, doxycycline, and ciprofloxacin, with treatment duration ranging from 7 days for cutaneous anthrax to 60 days for inhalational cases. - Prevention hinges on proper carcass disposal, livestock vaccination programs, and avoiding consumption of raw or undercooked meat from animals that died under suspicious circumstances.
